Stock Price Quote

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE604.20-0.45 (-0.07 %)
PREV CLOSE ( ) 604.65
OPEN PRICE ( ) 606.90
BID PRICE (QTY) 604.20 (1)
OFFER PRICE (QTY) 604.80 (1)
VOLUME 4508
TODAY'S LOW / HIGH ( )602.75 609.20
52 WK LOW / HIGH ( )602 856
NSE604.800.55 (+0.09 %)
PREV CLOSE( ) 604.25
OPEN PRICE ( ) 609.00
BID PRICE (QTY) 604.40 (11)
OFFER PRICE (QTY) 604.80 (2)
VOLUME 23164
TODAY'S LOW / HIGH( ) 603.60 609.00
52 WK LOW / HIGH ( )601.6 856.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1990
Management Info
C C Paarthipan - Chairman Sridhar Ganesan - Managing Director
Registered Office

Address 3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone 044-24968000 / 8012772888 / 71148000

Email info@caplinpoint.net

Website www.caplinpoint.net

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE, Chennai

NEWS

09Mar Caplin Point Laboratories trades highe
Caplin Point Laboratories is currently trading at Rs. 664.95, up by 3.85..
08Mar Caplin Point Laboratories’ arm gets US
Caplin Point Laboratories’ Subsidiary Company -- Caplin Steriles (Caplin..
08Mar Caplin Point Laboratories informs abou
Caplin Point Laboratories has informed that it enclosed Press Release re..
08Mar Announcement under Regulation 30 (LOD
Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point L..
03Mar Announcement under Regulation 30 (LOD
Attaching herewith a Press Release regarding grant of USFDA approval for..

Financials

in Millions
QTR Dec 22 ANNUAL 22
Net Profit591.71878.7
Gross Profit 743.6 2503.1
Operating Profit 808.72761.7
Net Sales 13065280.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  21622.75 (0.70%)
M.Cap ( in Cr)46009.41
Astrazeneca Pharma I (BSE)
peergroup  3332.75 (1.37%)
M.Cap ( in Cr)8292.38
Guj. Themis Biosyn (BSE)
peergroup  747.20 (4.50%)
M.Cap ( in Cr)1079.48
Neuland Laboratories (BSE)
peergroup  1682.00 (1.71%)
M.Cap ( in Cr)2151.57
Gland Pharma (BSE)
peergroup  1270.40 (2.04%)
M.Cap ( in Cr)20833.31

Shareholding Pattern

PROMOTERS 68.8%
NON-INSTITUTION 27.84%
MUTUAL FUNDS/UTI 1.04%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd. was incorporated in the year 1990. Its today's share price is 604.2. Its current market capitalisation stands at Rs 4597.05 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5280.6 Cr and Total Income of Rs.5847.5 Cr. The company's management includes R Nagendran, S Deenadhayalan, Dinesh RG, CK Gariyali, R Viswanathan, V Thirumalai, D Sathyanarayanan, Sridhar Ganesan, C C Paarthipan.

It is listed on the BSE with a BSE Code of 524742 , NSE with an NSE Symbol of CAPLIPOINT and ISIN of INE475E01026. It's Registered office is at 3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,PerungudiChennai-600096, Tamil Nadu. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are CNGSN & Associates, CNGSN & Associates LLP, M Raghunath & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)